JAK2 and leukemia: After 2 weeks of doxycycline chow, mice with JAK2 KO cells had a significantly reduced leukemia burden in bone marrow, spleen and peripheral blood (Fig. 2C), as well as decreased spleen weight (Fig. 2D).